Home > Boards > US Listed > Biotechs > Durect (DRRX)

Company regained and filed 8-K that they achieved

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dawsons creek Member Profile
 
Followed By 9
Posts 2,260
Boards Moderated 0
Alias Born 08/10/06
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 3/5/2021 3:47:56 PM
Durect EPS misses by $0.02, misses on revenue Seeking Alpha - 3/4/2021 4:18:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/4/2021 4:16:38 PM
DURECT Corporation Announces Fourth Quarter and Full Year 2020 Financial Results and Update of Programs PR Newswire (US) - 3/4/2021 4:05:00 PM
DURECT Corporation to Participate in Three Investor Conferences in March 2021 PR Newswire (US) - 3/3/2021 6:02:00 PM
DURECT Corporation to Announce 2020 Financial Results and Provide Business Update on March 4 PR Newswire (US) - 2/25/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/23/2021 9:01:18 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 6:23:59 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 3:52:25 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 10:57:51 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/5/2021 4:50:42 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/5/2021 4:46:56 PM
DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock PR Newswire (US) - 2/4/2021 9:18:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/4/2021 6:04:44 AM
DURECT Corporation Announces Proposed Offering of Common Stock PR Newswire (US) - 2/3/2021 4:01:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/2/2021 3:15:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/2/2021 9:01:05 AM
DURECT Corporation Announces U.S. FDA Approval of POSIMIR® For Post-Surgical Pain Reduction for up to 72 Hours Following Art... PR Newswire (US) - 2/2/2021 8:01:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/25/2021 9:06:59 AM
DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study of DUR-928 in Severe Alcohol-Associated Hepatitis PR Newswire (US) - 1/25/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2021 9:01:06 AM
DURECT Corporation Appoints Two New Board Members PR Newswire (US) - 1/5/2021 8:30:00 AM
DURECT Corporation Announces Closing of LACTEL® Absorbable Polymer Product Line Sale to Evonik and Receipt of $15 Million PR Newswire (US) - 1/4/2021 8:30:00 AM
DURECT Corporation to Participate in Investor Conferences in January 2021 PR Newswire (US) - 12/21/2020 8:30:00 AM
DURECT Corporation Announces DUR-928 Granted FDA Fast Track Designation for Treatment of Alcoholic Hepatitis PR Newswire (US) - 12/16/2020 8:30:00 AM
dawsons creek   Tuesday, 08/13/19 05:15:02 PM
Re: None
Post # of 989 
Company regained and filed 8-K that they achieved their good graces in the eyes of the nasdaq and back listed! Good news!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences